Matches in Wikidata for { <http://www.wikidata.org/entity/Q93214688> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q93214688 description "clinical trial" @default.
- Q93214688 description "ensayo clínico" @default.
- Q93214688 description "ensayu clínicu" @default.
- Q93214688 description "klinisch onderzoek" @default.
- Q93214688 description "клінічне випробування" @default.
- Q93214688 description "կլինիկական փորձարկում" @default.
- Q93214688 description "临床试验" @default.
- Q93214688 name "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 name "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 type Item @default.
- Q93214688 label "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 label "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 prefLabel "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 prefLabel "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 P1050 Q93214688-3D6510EA-05A9-49DF-85C4-CBC511309FCE @default.
- Q93214688 P1050 Q93214688-DA9D4577-732F-421B-B4A6-69E876E15C06 @default.
- Q93214688 P1132 Q93214688-D84B2FB6-828E-407D-8F6F-0C2630BD8BA1 @default.
- Q93214688 P1476 Q93214688-C582D078-0C7C-4FFE-A5C7-3A5B8ED9A60B @default.
- Q93214688 P2899 Q93214688-B834F77D-9CDC-4E22-B7EE-97ACEF1A6AD9 @default.
- Q93214688 P3098 Q93214688-FB4C14A3-DC72-406E-B04B-002339C8C802 @default.
- Q93214688 P31 Q93214688-8236E28D-5C8C-45B0-9D0E-F11135F39242 @default.
- Q93214688 P4844 Q93214688-76FED9A0-849E-4128-A440-9246AAB89BA5 @default.
- Q93214688 P580 Q93214688-F6649885-E9D4-4D26-A7D9-14D255CEB1B0 @default.
- Q93214688 P582 Q93214688-7D105CF4-9708-4D0E-B70D-18423F3ED14D @default.
- Q93214688 P6099 Q93214688-5B1A50F9-A86C-4A4F-8BA2-ADDE5DF1B5F5 @default.
- Q93214688 P8005 Q93214688-A203C257-AB40-4053-B281-FB49FBB8EE3C @default.
- Q93214688 P8363 Q93214688-B8B50DAC-B35A-4B07-AF8B-9602874BF626 @default.
- Q93214688 P1050 Q103177 @default.
- Q93214688 P1050 Q12206 @default.
- Q93214688 P1132 "+100" @default.
- Q93214688 P1476 "Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19" @default.
- Q93214688 P2899 "+18" @default.
- Q93214688 P3098 "NCT04371978" @default.
- Q93214688 P31 Q30612 @default.
- Q93214688 P4844 Q909745 @default.
- Q93214688 P580 "2020-05-15T00:00:00Z" @default.
- Q93214688 P582 "2021-06-30T00:00:00Z" @default.
- Q93214688 P6099 Q42824827 @default.
- Q93214688 P8005 Q76649614 @default.
- Q93214688 P8363 Q78089383 @default.